To study the effect of Turmeric capsules in healthy adult female participants.
- Registration Number
- CTRI/2024/06/068637
- Lead Sponsor
- utriventia Limited Unit
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Healthy women participants from 18-40 years of age declared healthy after assessing
medical history, physical examination and clinical judgment of the investigator.
2. Presence of blemish on face (Post inflammatory hyperpigmentation, acne marks, age
spots, sun spots) with otherwise healthy skin on the test area.
3. Willingness to discontinue the use of other cosmetic products on face during the course
of the study.
4. Accepting not to use topical or / and oral products with the same end benefit or products
containing sunscreen which might interfere with the study results, during the entire study
duration.
5. Cooperating, informed of the need and duration of the examinations, and ready to comply
with protocol procedures.
6. Having signed a Consent Form, after being informed orally and in writing of all
information concerning the study procedures and study objectives.
7. Willingness to avoid intense UV exposure as far as possible for the entire study duration.
8. Results of screening test are within normal range or considered not clinically significant
by the principal Investigator.
1. Male participants.
2. Peri-menopausal and post-menopausal women.
3. Pregnant women as confirmed by UPT or lactating women.
4. Presence of any cutaneous conditions on test site (scars, moles, papules etc).
5. Presence of any clinically significant systemic or cutaneous disease, which may interfere
with study treatments or procedures.
6. History or presence of substance abuse (alcohol, drugs, smoking).
7. Subject likely to undergo any surgery during the period of the study or within 01 month
of study completion.
8. Participation in any other experimental Investigational study within last 1 month as
identified during screening on visit 1 (V1).
9. Presence of any hard damage to skin (e.g., excessive sunburn or suntan).
10. History of use of collagen peptide containing supplement in the past 6 months.
11. History of consumption of high doses of vitamin C (>500 mg a day) or any other high
dose antioxidant product in the past 1 month.
12. Subjects on any nutritional supplement or consuming any therapeutic medication for any
disorder for last 45 days.
13. Subjects with known allergies to any of the ingredients of the study products
14. Individuals with chronic gastrointestinal issues such as frequent indigestion, GERD.
15. Subjects with severe acne.
16. Subjects with the history of gallstones or bile duct obstruction disorders.
17. Subjects with the history of bleeding disorders.
18. Difficulty in swallowing and retaining oral formulation.
19. Any history of difficulty in accessing veins to draw blood.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method